Document ID: chunk:federal_register_of_legislation:F2017C00842:reg:9:p1
Version: federal_register_of_legislation:F2017C00842
Segment Type: reg
Provision Reference: reg 9 (pt 1/2)
Character Range: 6082–9012

9               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, malignant neoplasm of the endometrium or death from malignant neoplasm of the endometrium is connected with the circumstances of a person's relevant service:
(1)          for females aged over 35 years only, being nulliparous at the time of the clinical onset of malignant neoplasm of the endometrium;
Note: nulliparous is defined in the Schedule 1 - Dictionary.
(2)          using oestrogen-only hormone replacement therapy for at least six months before the clinical onset of malignant neoplasm of the endometrium, and where the use of oestrogen-only hormone replacement therapy has ceased, the clinical onset of malignant neoplasm of the endometrium has occurred within 20 years of cessation;
Note: oestrogen-only hormone replacement therapy is defined in the Schedule 1 - Dictionary.
(3)          having cyclical combined hormone replacement therapy for a continuous period of at least two years before the clinical onset of malignant neoplasm of the endometrium, and where the use of cyclical combined hormone replacement therapy has ceased, the clinical onset of malignant neoplasm of the endometrium has occurred within five years of cessation;
Note: cyclical combined hormone replacement therapy is defined in the Schedule 1 - Dictionary.
(4)          having polycystic ovary syndrome at the time of the clinical onset of malignant neoplasm of the endometrium;
Note: polycystic ovary syndrome is defined in the Schedule 1 - Dictionary.
(5)          for post-menopausal females only, undergoing treatment with tamoxifen for a period of at least 12 months before the clinical onset of malignant neoplasm of the endometrium, and where treatment has ceased, the clinical onset of malignant neoplasm of the endometrium has occurred within ten years of that period;
(6)          using the sequential oral contraceptive pill Oracon within the 20 years before the clinical onset of malignant neoplasm of the endometrium;
Note: sequential oral contraceptive pill Oracon is defined in the Schedule 1 - Dictionary.
(7)          being overweight or obese for a period of at least ten years within the 20 years before the clinical onset of malignant neoplasm of the endometrium;
Note: being overweight or obese is defined in the Schedule 1 - Dictionary.
(8)          an inability to undertake any physical activity greater than three METs for at least 20 years within the 30 years before the clinical onset of malignant neoplasm of the endometrium;
Note: MET is defined in the Schedule 1 - Dictionary.
(9)          having diabetes mellitus for at least ten years before the clinical onset of malignant neoplasm of the endometrium;
(10)      for post-menopausal females with a history of a regular smoking habit as specified only, having not smoked for the ten years before the clinical